|
|
|
The
aim of this study is to perform a prognostic retrospective
follow-up study by collecting data from women with bleeding
disorders (including carriers of haemophilia, von Willebrand
disease, rare bleeding disorders, platelet disorders) as
well as from non-affected women coming from the same socio-economic
and cultural background in order to increase our knowledge
on the morbidity associated with bleeding disorders in affected
women.
|
|
The primary goals
are: |
|
- To establish an
International network of treatment centres
- To evaluate the severity and prevalence of bleeding symptoms
and gynaecological problems in affected and apparently healthy
women
- To identify healthy women with menorrhagia and determine
if they have a detectable bleeding disorder
- To evaluate the available types of treatments for women
with bleeding disorders, located in different parts of the
world:
- To determine the best treatment options to reduce the
complications of menorrhagia and others gynaecological problems
|
|
These goals will
be reached by the analysis of complete and detailed information
on clinical history, bleeding symptoms and treatment of
women, retrospectively collected by a specially formulated
clinical questionnaire (see
Annex II). Afterwards, an advisory board will be set
up to analyse the data and decide how to proceed with further
studies. This working group, formed by experienced epidemiologists,
gynaecologists and haematologists, will draw up an international
prospective study to address the unsolved issues related
to bleeding in women, such as: |
|
- To determine the
impact of bleeding disorders on a woman's lifestyle and
quality of life
- To increase early identification of at-risk and underserved
women during adolescence, reproductive age, and perimenopausal
age who would benefit from evaluation for bleeding disorders:
- To standardise testing to diagnose bleeding disorders
- To collaborate with other medical and surgical specialists
to coordinate the diagnosis and medical care of bleeding
in women
- To follow longitudinally the outcomes of enrolled women
diagnosed with bleeding disorders to assess the benefits
of early detection in intervention
- To determine the best treatment options for women with
bleeding disorders by assessing non-invasive treatments
to reduce the complications of menorrhagia and others gynaecological
problems. |
|
How to collaborate
with us |
|
The web-site www.rbdd.org
will be the contact site where two questionnaires (in word
or pdf) can be downloaded. The first collects general information
that enables us to learn how many Centres would like to
participate and how many women could be enrolled (see
Annex I). The second questionnaire (see
Annex II) is to collect complete and detailed information
regarding clinical history, bleeding symptoms and gynaecological
problems of women.
|
|
To compare the bleeding
symptoms and gynaecological problems between affected and
apparently non-affected women, there should be one apparently
non-affected control for every patient participating, and
they both should |
|
|
|
|
|